| scholarly article | Q13442814 |
| P50 | author | André Schmidt | Q73553936 |
| Fredy R S Gutierrez | Q81419667 | ||
| Paulo Marcos Matta Guedes | Q90467214 | ||
| P2093 | author name string | Anis Rassi | |
| Gerson Jhonatan Rodrigues | |||
| João Santana Silva | |||
| Lusiane Maria Bendhack | |||
| Benedito Carlos Maciel | |||
| Grace Kelly Silva | |||
| Renata Dellalibera-Joviliano | |||
| José Antonio Marin Neto | |||
| P2860 | cites work | Increased plasma levels of tumor necrosis factor-alpha in asymptomatic/"indeterminate" and Chagas disease cardiomyopathy patients | Q58846005 |
| Chagasic patients develop a type 1 immune response to Trypanosoma cruzi trans-sialidase | Q58846974 | ||
| IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance | Q58855387 | ||
| Cardiac troponin T in patients with clinically suspected myocarditis | Q73832142 | ||
| IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani | Q24658015 | ||
| The inhibitory cytokine IL-35 contributes to regulatory T-cell function | Q28258462 | ||
| Interleukin-17 family members and inflammation | Q28287876 | ||
| A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 | Q29547855 | ||
| Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation | Q29614840 | ||
| IL-17 produced during Trypanosoma cruzi infection plays a central role in regulating parasite-induced myocarditis | Q33532584 | ||
| Role of Foxp3-positive regulatory T cells during infection | Q33737475 | ||
| The role of the immune response on the development of severe clinical forms of human Chagas disease | Q33839414 | ||
| Regulatory T cells phenotype in different clinical forms of Chagas' disease | Q33927456 | ||
| Type 1 chemokine receptor expression in Chagas' disease correlates with morbidity in cardiac patients. | Q34194841 | ||
| CD4(+)CD25(+)Foxp3(+) regulatory T cells promote Th17 cells in vitro and enhance host resistance in mouse Candida albicans Th17 cell infection model | Q34627919 | ||
| Chemokines, inflammation and Trypanosoma cruzi infection. | Q34660986 | ||
| IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist | Q35022575 | ||
| Endogenous CD4(+) CD25(+) regulatory T cells have a limited role in the control of Trypanosoma cruzi infection in mice | Q35689168 | ||
| Regulatory T cells and infection: a dangerous necessity | Q36975739 | ||
| Human regulatory T cells: role in autoimmune disease and therapeutic opportunities | Q37211296 | ||
| Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response | Q39730057 | ||
| Chagas disease: what is known and what is needed--a background article | Q40147985 | ||
| Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection. | Q40788068 | ||
| Are increased frequency of macrophage-like and natural killer (NK) cells, together with high levels of NKT and CD4+CD25high T cells balancing activated CD8+ T cells, the key to control Chagas' disease morbidity? | Q42497203 | ||
| Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy | Q42971266 | ||
| IL-17 is necessary for host protection against acute-phase Trypanosoma cruzi infection | Q43012403 | ||
| Cyclic AMP decreases the production of NO and CCL2 by macrophages stimulated with Trypanosoma cruzi GPI-mucins | Q44055558 | ||
| Experimental chemotherapy against Trypanosoma cruzi infection: essential role of endogenous interferon-gamma in mediating parasitologic cure | Q44116597 | ||
| Frequency of interferon- gamma -producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease | Q44771953 | ||
| The involvement of CD4+CD25+ T cells in the acute phase of Trypanosoma cruzi infection. | Q45339719 | ||
| Cutting edge: Foxp3+CD4+CD25+ regulatory T cells induced by IL-2 and TGF-beta are resistant to Th17 conversion by IL-6. | Q45998381 | ||
| Beneficial effects of benznidazole during an infectious-based situation of systemic inflammatory response: cecal ligation and puncture. | Q46266746 | ||
| Foxp3(+) regulatory T cells promote T helper 17 cell development in vivo through regulation of interleukin-2. | Q46499482 | ||
| Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10. | Q47726082 | ||
| IFN-gamma in human Chagas' disease: protection or pathology? | Q47758411 | ||
| Immunological imbalance between IFN-gamma and IL-10 levels in the sera of patients with the cardiac form of Chagas disease. | Q51775764 | ||
| Andean subregional Chagas disease area and the Andean initiative of Chagas disease. | Q52684418 | ||
| Characterization of cytokine production in murine Trypanosoma cruzi infection by in situ immunocytochemistry: lack of association between susceptibility and type 2 cytokine production. | Q54154405 | ||
| Potential role of CD4+CD25HIGH regulatory T cells in morbidity in Chagas disease | Q56901414 | ||
| Cytokine mRNA profile of peripheral blood mononuclear cells isolated from individuals with Trypanosoma cruzi chronic infection | Q58843253 | ||
| Antibodies to Trypanosoma cruzi express idiotypic patterns that can differentiate between patients with asymptomatic or severe Chagas' disease | Q58844351 | ||
| The regulatory CD4+CD25+ T cells have a limited role on pathogenesis of infection with Trypanosoma cruzi | Q58844686 | ||
| [Patients suffering dilated chagasic cardiopathy or non chagasic cardiopathy show an increased levels of tumor necrosis factor alpha] | Q58845512 | ||
| Chagasic patients with indeterminate clinical form of the disease have high frequencies of circulating CD3+CD16-CD56+ natural killer T cells and CD4+CD25High regulatory T lymphocytes | Q58845519 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Chagas disease | Q649558 |
| cardiomyopathy | Q847583 | ||
| P304 | page(s) | e1630 | |
| P577 | publication date | 2012-04-24 | |
| P1433 | published in | PLoS Neglected Tropical Diseases | Q3359737 |
| P1476 | title | Deficient regulatory T cell activity and low frequency of IL-17-producing T cells correlate with the extent of cardiomyopathy in human Chagas' disease | |
| P478 | volume | 6 |
| Q40675193 | A prime-boost immunization with Tc52 N-terminal domain DNA and the recombinant protein expressed in Pichia pastoris protects against Trypanosoma cruzi infection |
| Q64282227 | A retrospective study on the influence of siblings' relatedness in Bolivian patients with chronic Chagas disease |
| Q91415039 | A systematic review of the Trypanosoma cruzi genetic heterogeneity, host immune response and genetic factors as plausible drivers of chronic chagasic cardiomyopathy |
| Q60920705 | Activation of Human CD11b B1 B-Cells by -Derived Proteins Is Associated With Protective Immune Response in Human Chagas Disease |
| Q34775976 | Analysis of the dynamics of infiltrating CD4(+) T cell subsets in the heart during experimental Trypanosoma cruzi infection |
| Q47093622 | Benznidazole affects expression of Th1, Th17 and Treg cytokines during acute experimental Trypanosoma cruzi infection. |
| Q38195336 | Biological markers for evaluating therapeutic efficacy in Chagas disease, a systematic review. |
| Q26744762 | Chemokines and Heart Disease: A Network Connecting Cardiovascular Biology to Immune and Autonomic Nervous Systems |
| Q39146653 | Chronic Chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) trial |
| Q35114499 | Cytokine profiling in Chagas disease: towards understanding the association with infecting Trypanosoma cruzi discrete typing units (a BENEFIT TRIAL sub-study). |
| Q41552272 | Depletion of regulatory T cells decreases cardiac parasitosis and inflammation in experimental Chagas disease |
| Q90482274 | Determination of the Th1, Th2, Th17, and Treg cytokine profile in patients with chronic Chagas heart disease and systemic arterial hypertension |
| Q35683779 | Differential Activation of Human Monocytes and Lymphocytes by Distinct Strains of Trypanosoma cruzi |
| Q36317381 | Differential cytokine profiling in Chagasic patients according to their arrhythmogenic-status |
| Q42369872 | Ebi3 Prevents Trypanosoma cruzi-Induced Myocarditis by Dampening IFN-γ-Driven Inflammation |
| Q34478887 | Effects of omega-3 polyunsaturated fatty acid supplementation in patients with chronic chagasic cardiomyopathy: study protocol for a randomized controlled trial |
| Q55341632 | Electrocardiographic abnormalities in Chagas disease in the general population: A systematic review and meta-analysis. |
| Q90471667 | Genetic polymorphisms of IL17A associated with Chagas disease: results from a meta-analysis in Latin American populations |
| Q35065274 | Genetic susceptibility to Chagas disease cardiomyopathy: involvement of several genes of the innate immunity and chemokine-dependent migration pathways. |
| Q58572827 | IL-17RA-Signaling Modulates CD8+ T Cell Survival and Exhaustion During Infection |
| Q41745518 | Increase in the expression of CD4 + CD25+ lymphocytic T cells in the indeterminate clinical form of human Chagas disease after stimulation with recombinant antigens of Trypanosoma cruzi |
| Q35999538 | Inflammation Enhances the Risks of Stroke and Death in Chronic Chagas Disease Patients |
| Q39555510 | Inflammatory responses and intestinal injury development during acute Trypanosoma cruzi infection are associated with the parasite load |
| Q90467218 | Innate immune receptors over expression correlate with chronic chagasic cardiomyopathy and digestive damage in patients |
| Q41719512 | Interleukin 17A acts synergistically with interferon γ to promote protection against Leishmania infantum infection |
| Q40968042 | Interleukin-17, oxidative stress, and inflammation: role of melatonin during Trypanosoma cruzi infection |
| Q92405091 | Intermediate Monocytes and Cytokine Production Associated With Severe Forms of Chagas Disease |
| Q59136942 | Limited Foxp3 Regulatory T Cells Response During Acute Infection Is Required to Allow the Emergence of Robust Parasite-Specific CD8 T Cell Immunity |
| Q28083346 | Modulation of Trypanosoma cruzi-specific T-cell responses after chemotherapy for chronic Chagas disease |
| Q34053139 | Myocardial gene expression of T-bet, GATA-3, Ror-γt, FoxP3, and hallmark cytokines in chronic Chagas disease cardiomyopathy: an essentially unopposed TH1-type response |
| Q49531175 | New Insights into the Immunobiology of Mononuclear Phagocytic Cells and Their Relevance to the Pathogenesis of Cardiovascular Diseases |
| Q33785166 | Omega-3 supplementation on inflammatory markers in patients with chronic Chagas cardiomyopathy: a randomized clinical study. |
| Q36305471 | P2×7 purinergic signaling in dilated cardiomyopathy induced by auto-immunity against muscarinic M2 receptors: autoantibody levels, heart functionality and cytokine expression |
| Q39244146 | Participation of TLR2 and TLR4 in Cytokines Production by Patients with Symptomatic and Asymptomatic Chronic Chagas Disease. |
| Q57789637 | Pathology and Pathogenesis of Chagas Heart Disease |
| Q34075123 | Presence of antigen-experienced T cells with low grade of differentiation and proliferative potential in chronic Chagas disease myocarditis |
| Q54255041 | Regulatory Lymphoid and Myeloid Cells Determine the Cardiac Immunopathogenesis of Trypanosoma cruzi Infection. |
| Q64949232 | Regulatory Role of CD4+ T Cells in Myocarditis. |
| Q26738824 | Scrutinizing the Biomarkers for the Neglected Chagas Disease: How Remarkable! |
| Q40673184 | Serum Cytokines as Biomarkers of Early Trypanosoma cruzi infection by Congenital Exposure. |
| Q48099205 | Specific activation of CD4- CD8- double-negative T cells by Trypanosoma cruzi-derived glycolipids induces a proinflammatory profile associated with cardiomyopathy in Chagas patients. |
| Q28079006 | The CXCL10/CXCR3 Axis and Cardiac Inflammation: Implications for Immunotherapy to Treat Infectious and Noninfectious Diseases of the Heart |
| Q58705710 | The Unsolved Jigsaw Puzzle of the Immune Response in Chagas Disease |
| Q37198750 | The heart of the matter: protection of the myocardium from T cells |
| Q35112512 | The involvement of TLR2 and TLR4 in cytokine and nitric oxide production in visceral leishmaniasis patients before and after treatment with anti-leishmanial drugs |
| Q36302693 | The role of interleukin 17-mediated immune response in Chagas disease: High level is correlated with better left ventricular function |
| Q27303853 | Trypanosoma cruzi Experimental Infection Impacts on the Thymic Regulatory T Cell Compartment |
| Q64910433 | Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes as a Model to Study Trypanosoma cruzi Infection. |
| Q58583576 | Vasoactive intestinal peptide degradation might influence Interleukin-17 expression in cardiac chagasic patients |
Search more.